Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
November 14, 2009
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease
Ajit Jadhav, Rafaela S Ferreira, Carleen Klumpp, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 4, 2013
In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility
Rebecca S Treger, Joseph Otchere, Martin F Keil, et al.
Journal of Medicinal Chemistry
|
December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine
Rachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)
Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)
Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Blood Advances
|
February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Blake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Oncotarget
|
January 16, 2016
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
Jennifer M Fox, James R Moynihan, Bryan T Mott, et al.
Scientific Reports
|
November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Lu Chen, Kelli Wilson, Ian Goldlust, et al.
Oncogene
|
April 17, 2022
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
Joshua D Bernstock, Kyung-Don Kang, Neil V Klinger, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
November 14, 2009
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease
Ajit Jadhav, Rafaela S Ferreira, Carleen Klumpp, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 4, 2013
In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility
Rebecca S Treger, Joseph Otchere, Martin F Keil, et al.
Journal of Medicinal Chemistry
|
December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine
Rachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)
Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Journal of Medicinal Chemistry
|
June 15, 2010
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
Rafaela S Ferreira, Anton Simeonov, Ajit Jadhav, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)
Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Blood Advances
|
February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Blake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Oncotarget
|
January 16, 2016
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
Jennifer M Fox, James R Moynihan, Bryan T Mott, et al.
Scientific Reports
|
November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Lu Chen, Kelli Wilson, Ian Goldlust, et al.
Oncogene
|
April 17, 2022
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
Joshua D Bernstock, Kyung-Don Kang, Neil V Klinger, et al.
Page
of 6